Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-06-06

FDA Approved: ZALEPLON — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Rising Pharma Holdings, Inc.'s original ANDA for Zaleplon, a generic short-acting hypnotic used to treat insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zaleplon (Zaleplon)

Snippet

ORIG AP for ZALEPLON (ZALEPLON)